Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Public ClinicalTrials.gov record NCT05703971. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid and Atezolizumab Maintenance Therapy in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Study identification
- NCT ID
- NCT05703971
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Genprex, Inc.
- Industry
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Interventions
- quaratusugene ozeplasmid Biological
- atezolizumab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 8, 2024
- Primary completion
- May 31, 2026
- Completion
- Jul 31, 2027
- Last update posted
- Jun 2, 2026
2024 – 2027
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rocky Mountain Cancer Centers, LLP | Lone Tree | Colorado | 80124 | Recruiting |
| Washington University School of Medicine - Siteman Cancer Center | St Louis | Missouri | 63110 | Recruiting |
| Gabrail Cancer Center Research | Canton | Ohio | 44718 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45211 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45236 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45242 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45245 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Fairfield | Ohio | 45014 | Recruiting |
| Willamette Valley Cancer Institute (Oregon) | Eugene | Oregon | 97401 | Recruiting |
| Northwest Cancer Specialists, P.C. | Portland | Oregon | 97213-2982 | Recruiting |
| Providence Cancer Institute | Portland | Oregon | 97213 | Recruiting |
| Northwest Cancer Specialists, P.C. | Portland | Oregon | 97227 | Recruiting |
| Northwest Cancer Specialists, P.C. | Tigard | Oregon | 97223 | Recruiting |
| Texas Oncology - DFW | Dallas | Texas | 75246 | Recruiting |
| Texas Oncology - Northeast Texas | Tyler | Texas | 75702 | Recruiting |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | Recruiting |
| Northwest Cancer Specialists, P.C. | Vancouver | Washington | 98684 | Terminated |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05703971, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05703971 live on ClinicalTrials.gov.